Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data

Plaque psoriasis (PSO) and lichen planus (LP) are skin diseases with some similarities in pathogenesis, comorbidities, and clinical presentation. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and its ligand, α<sub>4</sub>β<sub>7</sub> integrin, are involved in inflamm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna Baran, Julia Nowowiejska, Tomasz W. Kamiński, Julita A. Krahel, Iwona Flisiak
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/060788058e9c4fc49ee3f56cccaea6ae
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:060788058e9c4fc49ee3f56cccaea6ae
record_format dspace
spelling oai:doaj.org-article:060788058e9c4fc49ee3f56cccaea6ae2021-11-25T16:47:15ZCirculating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data10.3390/biology101111292079-7737https://doaj.org/article/060788058e9c4fc49ee3f56cccaea6ae2021-11-01T00:00:00Zhttps://www.mdpi.com/2079-7737/10/11/1129https://doaj.org/toc/2079-7737Plaque psoriasis (PSO) and lichen planus (LP) are skin diseases with some similarities in pathogenesis, comorbidities, and clinical presentation. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and its ligand, α<sub>4</sub>β<sub>7</sub> integrin, are involved in inflammatory bowel diseases and liver dysfunctions, which occur more frequently in PSO and LP. Serum MAdCAM-1 and ITGB7 levels in patients with plaque PSO and eruptive LP have never been studied before. The study included 42 patients with PSO, 13 with LP, and 23 controls. Serum molecules levels were evaluated using the immune–enzymatic method. ITGB7 concentration was not statistically different, both in patients with PSO and LP, compared to controls (both <i>p</i> > 0.05). MAdCAM-1 level was significantly lower in PSO subjects than in controls (<i>p</i> = 0.041), whereas in the LP group, a downward trend was observed (<i>p</i> = 0.088) with <i>p</i> = 0.0455 in ANOVA. Multiple linear regression revealed independent associations between ITGB7 and HDL and BMI and RBC in the LP group. In psoriatic patients with elevated CRP, there was an upward trend for MAdCAM-1, and also a positive correlation between MAdCAM-1 and WBC. ITGB7 and MAdCAM-1 cannot serve as markers of disease activity or liver pathology neither in patients with PSO nor LP. MAdCAM-1 might play a role as an inflammation indicator in PSO and a beneficial influence on the lipid profile in LP.Anna BaranJulia NowowiejskaTomasz W. KamińskiJulita A. KrahelIwona FlisiakMDPI AGarticlepsoriasislichen planusα<sub>4</sub>β<sub>7</sub> integrinMAdCAM-1ITGB7mucosal addressin cell adhesion molecule-1Biology (General)QH301-705.5ENBiology, Vol 10, Iss 1129, p 1129 (2021)
institution DOAJ
collection DOAJ
language EN
topic psoriasis
lichen planus
α<sub>4</sub>β<sub>7</sub> integrin
MAdCAM-1
ITGB7
mucosal addressin cell adhesion molecule-1
Biology (General)
QH301-705.5
spellingShingle psoriasis
lichen planus
α<sub>4</sub>β<sub>7</sub> integrin
MAdCAM-1
ITGB7
mucosal addressin cell adhesion molecule-1
Biology (General)
QH301-705.5
Anna Baran
Julia Nowowiejska
Tomasz W. Kamiński
Julita A. Krahel
Iwona Flisiak
Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
description Plaque psoriasis (PSO) and lichen planus (LP) are skin diseases with some similarities in pathogenesis, comorbidities, and clinical presentation. Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and its ligand, α<sub>4</sub>β<sub>7</sub> integrin, are involved in inflammatory bowel diseases and liver dysfunctions, which occur more frequently in PSO and LP. Serum MAdCAM-1 and ITGB7 levels in patients with plaque PSO and eruptive LP have never been studied before. The study included 42 patients with PSO, 13 with LP, and 23 controls. Serum molecules levels were evaluated using the immune–enzymatic method. ITGB7 concentration was not statistically different, both in patients with PSO and LP, compared to controls (both <i>p</i> > 0.05). MAdCAM-1 level was significantly lower in PSO subjects than in controls (<i>p</i> = 0.041), whereas in the LP group, a downward trend was observed (<i>p</i> = 0.088) with <i>p</i> = 0.0455 in ANOVA. Multiple linear regression revealed independent associations between ITGB7 and HDL and BMI and RBC in the LP group. In psoriatic patients with elevated CRP, there was an upward trend for MAdCAM-1, and also a positive correlation between MAdCAM-1 and WBC. ITGB7 and MAdCAM-1 cannot serve as markers of disease activity or liver pathology neither in patients with PSO nor LP. MAdCAM-1 might play a role as an inflammation indicator in PSO and a beneficial influence on the lipid profile in LP.
format article
author Anna Baran
Julia Nowowiejska
Tomasz W. Kamiński
Julita A. Krahel
Iwona Flisiak
author_facet Anna Baran
Julia Nowowiejska
Tomasz W. Kamiński
Julita A. Krahel
Iwona Flisiak
author_sort Anna Baran
title Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
title_short Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
title_full Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
title_fullStr Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
title_full_unstemmed Circulating MAdCAM-1 and ITGB7 in Patients with Plaque Psoriasis and Eruptive Lichen Planus—Preliminary Data
title_sort circulating madcam-1 and itgb7 in patients with plaque psoriasis and eruptive lichen planus—preliminary data
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/060788058e9c4fc49ee3f56cccaea6ae
work_keys_str_mv AT annabaran circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata
AT julianowowiejska circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata
AT tomaszwkaminski circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata
AT julitaakrahel circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata
AT iwonaflisiak circulatingmadcam1anditgb7inpatientswithplaquepsoriasisanderuptivelichenplanuspreliminarydata
_version_ 1718412937708699648